medline.ch Onkologie Urologische Tumoren

	Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer. Scand J Urol Heiskanen E, Kalinen S, Chu RJ, Högerman M, Lamminen T, Taimen P, Jambor I, Aronen H, Merisaari H, Sainio T, Hakanen A, Ettala O, Laitinen K, Vasankari T, Kallonen T, Boström PJ, Promic study group. PMID: 42707024 [PubMed - indexed for MEDLINE]
	Artificial Intelligence in equivocal prostatic needle biopsies: benign mimics and cancer detection. Arch Ital Urol Androl Bawahab AA. PMID: 42707010 [PubMed - as supplied by publisher]
	MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model. IUBMB Life Camargo JA, Lee MC, Souza MM, Silva LPD, Boas GCV, Silva KSD, Mioshi CM, Pimenta RCA, Candido P, Silva IAD, Trarbach EB, Leite KRM, Nahas WC, Reis STD. PMID: 42706676 [PubMed - indexed for MEDLINE]
	Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk. Nat Commun Prokunina-Olsson L, Florez-Vargas O, Levin MG, Dutta D, Breeze CE, Hurwitz LM, Yan W, Lamy P, Papenberg BW, Wang K, Lee CH, Milne RL, Gu J, Um CY, Joseph V, Furberg H, Le Calvez-Kelm F, Lori A, Choudhury PP, Afshar N, Kogevinas M, Offit K, Vermeulen SH, López de Maturana E, Albanes D, Purdue MP, Cortessis VK, Karagas MR, Kooperberg C, Bjurlin M, Tadesse DA, Moore SC, Huang WY, Haiman CA, Stern MC, Eliassen AH, Mucci LA, Aben KK, Galesloot TE, UROMOL Consortium, Verma A, Yoshino S, Hikino K, Terao C, Rafnar T, Matsuda K, Shuin T, Garcia-Closas M, Real FX, Kiemeney LA, Chanock SJ, Malats N, Silverman DT, Dyrskjot L, Rothman N, Damrauer SM, Koutros S, Damrauer JS. PMID: 42706231 [PubMed - indexed for MEDLINE]
	Re: Rana R. McKay, Karla V. Ballman, Pamela J. Atherton, et al. Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Renal Cell Carcinoma with Bone Metastases: RADICAL (Alliance A031801). J Clin Oncol. 2026;44:2341-52. Eur Urol Roviello G, Antonuzzo L. PMID: 42706004 [PubMed - as supplied by publisher]
	Transdermal Estradiol for Treating Prostate Cancer: Revisiting Huggins and Hodges' Revolutionary Breakthrough. Eur Urol Oncol Benjamin DJ, Rezazadeh Kalebasty A. PMID: 42705946 [PubMed - as supplied by publisher]
	A cfDNA fragmentomics classifier for noninvasive differentiation of benign and malignant renal masses. Mol Biomed Li L, Wang C, Wang S, Zheng J, Fu J, Wei L, Shen J, Li Y, Hong X, Wu C, Chen W, Gong W, Wang Y. PMID: 42704571 [PubMed - indexed for MEDLINE]
	Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements. J Hematop Kim B, Cha HJ. PMID: 42704559 [PubMed - indexed for MEDLINE]
	Sutureless versus renorrhaphy in robot-assisted off-clamp partial nephrectomy: a systematic review and meta-analysis. J Robot Surg Zeng X, Xu X, Luo J, Fu G. PMID: 42704544 [PubMed - indexed for MEDLINE]
	Smart Colloidal Systems as Drug Delivery and Therapeutic Modulation Platforms for Renal Cell Carcinoma. Int J Nanomedicine Sun L, Zhao X, Li X, Zhu Z, Wu G. PMID: 42703368 [PubMed - indexed for MEDLINE]
	Inflammasome-associated pyroptosis and tumor angiogenesis in prostate cancer. Iran J Basic Med Sci Al-Ameer HJ, Jameel RK, Nasretdinova M, Sultanov R, Polatova D, Alaal MA, Tailor NK, Singh R. PMID: 42703256 [PubMed]
	Predictive and prognostic biomarkers of Bacillus Calmette-GuÃ©rin therapy failure in bladder cancer patients: A systematic review. Mol Oncol Ribeiro-Pereira R, Teixeira-Marques A, Freitas R, Carvalho JA, Monteiro-Reis S, Russo GI, Henrique R, Jerónimo C. PMID: 42703096 [PubMed - as supplied by publisher]
	Multi-Omics Integration Identifies a Five-Gene Metabolic Signature With Experimental Validation in Clear Cell Renal Cell Carcinoma. Cancer Rep (Hoboken) Peng Y, Qin S, Li X, Wan L, Guan R. PMID: 42702836 [PubMed - indexed for MEDLINE]
	Segmental versus non-segmental inferior vena cava resection during robot-assisted radical nephrectomy and thrombectomy: an overlap-weighted analysis. World J Urol Guan Y, Yan Y, Xie R, Ge L, Tian X, Wang G, Ma L, Zhang H, Zhang S. PMID: 42701915 [PubMed - indexed for MEDLINE]
	Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming. Mamm Genome Mukherjee AG, Bharti AK, Mathew DM, Gopalakrishnan AV, Nishu S. PMID: 42701157 [PubMed - indexed for MEDLINE]
	Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group. Urol Oncol Corvino R, Basile G, Santarelli V, Asero V, De Berardinis E, Sciarra A, Vittori L, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Barod R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Suleja A, Grobet-Jeandin E, Mari A, Mertens LS, Moschini M, De Angelis M, Scillipoti P, Soria F, Bosio A, Teoh J, Claps F, Amodeo A, , Contieri R, Subiela D, Tagalos A, Tully KH, Pichler R, Antonelli A, Bertolo R, Veccia A, Malandra S, Hurle R, Sormani F, Crocetto F, Mayr R, Porreca A, Simone G, Tuderti G, Rocco B, Simonato A, Simonato FA, Marcq G, Gontero P, Tian Z, Karakiewicz P, Chung BI, Pradere B, Del Giudice F. PMID: 42701052 [PubMed - as supplied by publisher]
	Long-term exposure to trihalomethanes in drinking water and risk of liver and kidney cancer: a population-based cohort study. Environ Int Helte E, Säve-Söderbergh M, Åkesson A. PMID: 42700668 [PubMed - as supplied by publisher]
	Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing. Biomed Pharmacother Obeid K, Konijnenberg M, Bezverkhniaia E, Maina T, Nock BA, Tolmachev V, Kanellopoulos P, Orlova A. PMID: 42700618 [PubMed - as supplied by publisher]
	Integrative omics profiling of CRELD2 in ccRCC: a nexus of genetics, prognosis, and tumor microenvironment. Inflamm Res Liu S, Zhou Y, Fan L, Wang Y, Qu L, Zhou W. PMID: 42700259 [PubMed - indexed for MEDLINE]
	Risk of bone metastases on [(18)F]NaF PET/CT in 734 patients with newly diagnosed prostate cancer. Eur J Nucl Med Mol Imaging Madsen C, Zacho HD, Bisbjerg R, Fuglø D, Østergren PB. PMID: 42700249 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 181285

Seite 1 von 9065

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung